Objective efficacy of mirabegron on storage and voiding function in patients with over-active bladder that are unresponsive to antimuscarinic treatment: a urodynamic study.

Trial Profile

Objective efficacy of mirabegron on storage and voiding function in patients with over-active bladder that are unresponsive to antimuscarinic treatment: a urodynamic study.

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Oct 2015

At a glance

  • Drugs Mirabegron (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Oct 2015 Results (n=60) presented at the 45th Annual Meeting of the International Continence Society
    • 11 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top